RankingsPricing
  1. US-listed companies
  2. VERTEX PHARMACEUTICALS INC
  3. Financials
  4. EBITDA margin (%)

VERTEX PHARMACEUTICALS INC【VRTX】

Market cap
$119.1B
P/E ratio
SummaryFinancials
Period EndEBITDA margin (%) YoY (%)
Dec 31, 2024-0.2-100.57%
Dec 31, 202340.7-18.49%
Dec 31, 202249.9+29.97%
Dec 31, 202138.4-19.68%
Dec 31, 202047.8+52.51%
Dec 31, 201931.3+34.97%
Dec 31, 201823.2+212.93%
Dec 31, 20177.4+77.04%
Dec 31, 20164.2-110.69%
Dec 31, 2015-39.2-63.85%
Dec 31, 2014-108.4+53.64%
Dec 31, 2013-70.6-2758.67%
Dec 31, 20122.7-74.85%
Dec 31, 201110.6-102.27%
Dec 31, 2010-464.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)